Drugs that contain Oxybutynin

1. List of Gelnique 3% drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7198801 ALLERGAN Formulations for transdermal or transmucosal application
Jun, 2022

(11 months ago)

Do you want to check out GELNIQUE 3% patents from before 2022?

Market Authorisation Date: 07 December, 2011

Treatment: NA

Dosage: GEL, METERED;TRANSDERMAL

More Information on Dosage

GELNIQUE 3% family patents

18

United States

10

European Union

4

Austria

4

Japan

4

Australia

3

Spain

3

Germany

3

Canada

3

New Zealand

3

Mexico

2

China

2

Brazil

2

Korea, Republic of

2

South Africa

1

Hong Kong

1

Denmark

1

Poland

1

Argentina

1

Israel

1

Portugal

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic